Fresenius SE & Co KGaA/ DE0005785604 /
5/21/2025 11:58:25 AM | Chg. -0.44 | Volume | Bid4/4/2025 | Ask4/9/2025 | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
43.54EUR | -1.00% | 574 Turnover: 24,968.17 |
-Bid Size: - | -Ask Size: - | 24.54 bill.EUR | 2.30% | 51.87 |
GlobeNewswire
3/18
Leading Academic and Manufacturing Organizations Join Ori Biotech’s Preferred Partner Network to Acc...
GlobeNewswire
4/23/2024
Transferring Biomedical Research to Patients Faster: ForTra gGmbH Announces Positive Funding Track R...
GlobeNewswire
2/23/2024
Travere Therapeutics and CSL Vifor Announce Sparsentan Receives Positive CHMP Opinion for the Treatm...
GlobeNewswire
9/4/2023
CIO Leadership: Generative AI and Visionary Leadership in the Enterprise Will Power the Discussion a...
GlobeNewswire
8/31/2023
CytoSorbents Granted Expanded ANVISA Registration to Treat Shock with CytoSorb in Brazil